Amarin Corp Plc (AMRN)

[Whalatane]

Can U get to $1B in sales where the R-IT patent is protected … EU and ROW ?
If an average BO offer is 5 X peak sales that gets you to a valuation of $ 5B for a Co that is currently trading at $1.7B market cap
So as long as the generics can’t enter the EU and ROW a BO higher than where Co now trades is not unrealistic

I’m not expecting one as I expect KM wants his chance to execute his plan

Just saying it’s not unrealistic as long as generics can’t enter the EU or ROW

Kiwi